Deerfield Management Company
Latest statistics and disclosures from Deerfield Management Company's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Horizon Therapeutics Plc, Horizon Pharma Plc convertible security, Mylan Nv, Orchard Therapeutics Plc ads, Nevro Corp note 1.750% 6/0, and represent 24.92% of Deerfield Management Company's stock portfolio.
- Added to shares of these 10 stocks: Horizon Therapeutics Plc (+$155.49M), Mylan Nv (+$81.20M), Insulet Corp note 1.375%11/1 (+$52.04M), Aerie Pharmaceuticals (+$42.09M), Mallinckrodt Pub (+$38.36M), Coherus Biosciences (+$37.08M), Ptc Therapeutics Inc conv bd us (+$27.61M), STAA (+$25.75M), Intersect Ent (+$25.11M), Silk Road Medical Inc Common (+$24.18M).
- Started 19 new stock positions in Phasebio Pharmaceuticals Inc, Turning Point Therapeutics I, Global Blood Therapeutics In, X4 Pharmaceuticals Inc, Silk Road Medical Inc Common, Ideaya Biosciences Inc, MDCO, BDSI, Ptc Therapeutics Inc conv bd us, Adaptive Biotechnologies Cor. HUM, Sorrento Therapeutics, Horizon Therapeutics Plc, Chewy Inc cl a, Mallinckrodt Pub, Coherus Biosciences, Bridgebio Pharma Inc, Insulet Corp note 1.375%11/1, STAA.
- Reduced shares in these 10 stocks: Horizon Pharma (-$170.81M), Portola Pharmaceuticals (-$90.83M), CNC (-$19.09M), Glaukos (-$17.85M), Axogen (-$17.34M), Ascendis Pharma A S (-$16.97M), Argenx Se (-$15.96M), UHS (-$15.92M), Reata Pharmaceuticals Inc Cl A stock (-$15.76M), Nevro (-$12.54M).
- Sold out of its positions in Aac Holdings, Allogene Therapeutics Inc, Ascendis Pharma A S, Eyepoint Pharmaceuticals Inc, Glaukos, Teligent Inc note 3.750 12/1, Melinta Therapeutics Inc, Nuvasive Inc note 2.250% 3/1, Portola Pharmaceuticals, Savara. UHS, Axovant Sciences, Horizon Pharma, Meiragtx Holdings Plc, Osmotica Pharmaceuticals Plc.
- Deerfield Management Company was a net buyer of stock by $324.83M.
- Deerfield Management Company has $2.78B in assets under management (AUM), growing by 6.76%.
Companies in the Deerfield Management Company portfolio as of June 2019 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Horizon Therapeutics Plc | 5.59 | 6.46M | NEW | 24.06 |
| Horizon Pharma Plc convertible security | 5.42 | 136.03M | +17% | 1.11 |
| Mylan Nv | 5.10 | 7.46M | +133% | 19.04 |
| Orchard Therapeutics Plc ads | 4.48 | 8.92M | +11% | 13.99 |
| Nevro Corp note 1.750% 6/0 | 4.32 | 115.78M | +15% | 1.04 |
| Homology Medicines Inc | 4.05 | 5.76M | +10% | 19.57 |
| Aerie Pharmaceuticals | 3.22 | 3.03M | +88% | 29.55 |
| Intersect Ent | 2.54 | 3.11M | +54% | 22.76 |
| Immunomedics (IMMU) | 2.48 | 4.99M | +31% | 13.87 |
| Acceleron Pharma | 1.93 | 1.31M | +3% | 41.08 |
| Brookdale Senior Living (BKD) | 1.87 | 7.21M | +39% | 7.21 |
| Insulet Corp note 1.375%11/1 | 1.87 | 36.65M | NEW | 1.42 |
| Intercept Pharmas conv | 1.85 | 57.79M | 0.89 | |
| Ra Pharmaceuticals | 1.85 | 1.71M | +14% | 30.07 |
| Myokardia | 1.80 | 997000 | 50.14 | |
| Sarepta Therapeutics | 1.69 | 309025 | -19% | 151.95 |
| Diplomat Pharmacy | 1.54 | 7.04M | 6.09 | |
| Argenx Se | 1.43 | 281000 | -28% | 141.58 |
| Vericel | 1.40 | 2.07M | +22% | 18.89 |
| Mallinckrodt Pub | 1.38 | 4.18M | NEW | 9.18 |
| Coherus Biosciences | 1.33 | 1.68M | NEW | 22.10 |
| Blueprint Medicines | 1.33 | 391254 | -22% | 94.33 |
| Fate Therapeutics | 1.24 | 1.70M | 20.30 | |
| Alector Inc | 1.19 | 1.75M | -10% | 19.00 |
| Select Medical Holdings Corporation (SEM) | 1.16 | 2.04M | 15.87 | |
| Dexcom Inc dbcv 0.750% 5/1 | 1.15 | 20.00M | 1.60 | |
| Kempharm Inc note 5.500% 2/0 | 1.13 | 65.42M | 0.48 | |
| Anaptysbio Inc Common | 1.10 | 540529 | -27% | 56.42 |
| Sientra | 1.03 | 4.65M | +70% | 6.16 |
| Editas Medicine | 1.03 | 1.16M | 24.74 | |
| Natera | 0.99 | 1.00M | -24% | 27.58 |
| Ptc Therapeutics Inc conv bd us | 0.99 | 24.88M | NEW | 1.11 |
| Mirati Therapeutics | 0.98 | 264600 | +4% | 103.00 |
| Xeris Pharmaceuticals Inc | 0.98 | 2.38M | 11.44 | |
| Kalvista Pharmaceuticals | 0.97 | 1.22M | +87% | 22.15 |
| eHealth (EHTH) | 0.96 | 310900 | -29% | 86.10 |
| Dbv Technologies S A | 0.95 | 3.20M | +88% | 8.22 |
| Exact Sciences Corp convertible/ | 0.93 | 15.00M | 1.72 | |
| Dfb Healthcare Acquistion Co unit 01/30/2023 | 0.93 | 2.50M | 10.37 | |
| STAAR Surgical Company (STAA) | 0.92 | 876512 | NEW | 29.38 |
| Nevro | 0.90 | 386000 | -33% | 64.83 |
| Silk Road Medical Inc Common | 0.87 | 499030 | NEW | 48.46 |
| BioCryst Pharmaceuticals (BCRX) | 0.86 | 6.29M | -3% | 3.79 |
| Invitae | 0.84 | 995312 | +140% | 23.50 |
| Molina Healthcare (MOH) | 0.77 | 150000 | +74% | 143.14 |
| Ptc Therapeutics I | 0.76 | 471000 | +98% | 45.00 |
| Arvinas Ord | 0.73 | 921234 | 21.99 | |
| Wright Medical Group Nv 2.25 20211115 | 0.72 | 13.62M | 1.48 | |
| Addus Homecare Corp | 0.68 | 252915 | 74.95 | |
| Reata Pharmaceuticals Inc Cl A stock | 0.67 | 197000 | -45% | 94.35 |
| Audentes Therapeutics Inc Com stock | 0.67 | 493901 | 37.86 | |
| Humana (HUM) | 0.64 | 67000 | NEW | 265.30 |
| Kiniksa Pharmaceuticals Ltd | 0.64 | 1.31M | 13.54 | |
| Shockwave Med Inc | 0.64 | 312146 | 57.09 | |
| Axogen | 0.63 | 891306 | -49% | 19.80 |
| Wave Life Sciences Ltd shs | 0.63 | 669260 | +69% | 26.09 |
| Rocket Pharmaceuticals Inc | 0.61 | 1.14M | +306% | 15.00 |
| Centene Corporation (CNC) | 0.57 | 303000 | -54% | 52.44 |
| Clovis Oncology Inc note 2.500% 9/1 | 0.57 | 18.00M | +260% | 0.88 |
| Anthem | 0.54 | 53000 | 282.21 | |
| Morphosys Ag Adr | 0.52 | 600000 | 24.14 | |
| Deciphera Pharmaceuticals Inc | 0.49 | 607633 | 22.55 | |
| Rhythm Pharmaceuticals Inc | 0.49 | 623933 | +114% | 22.00 |
| Galapagos Nv-spon | 0.47 | 101010 | -42% | 128.93 |
| Global Blood Therapeutics In | 0.44 | 235000 | NEW | 52.60 |
| Athenex | 0.44 | 621859 | 19.80 | |
| Syros Pharmaceuticals | 0.42 | 1.27M | 9.26 | |
| Turning Point Therapeutics I | 0.42 | 287545 | NEW | 40.70 |
| Phasebio Pharmaceuticals Inc | 0.40 | 851005 | NEW | 13.12 |
| Synlogic, Inc. | 0.36 | 1.11M | 9.10 | |
| Tandem Diabetes Care Inc | 0.35 | 152500 | +329% | 64.52 |
| Ardelyx | 0.33 | 3.46M | +5% | 2.69 |
| Inspire Med Sys Inc | 0.33 | 151106 | +8% | 60.65 |
| Chewy Inc cl a | 0.33 | 261337 | NEW | 35.00 |
| Aclaris Therapeutics | 0.31 | 3.98M | -32% | 2.19 |
| X4 Pharmaceuticals Inc | 0.30 | 565000 | NEW | 15.00 |
| Flamel Technologies Sa | 0.28 | 2.72M | 2.89 | |
| Bridgebio Pharma Inc | 0.28 | 290000 | NEW | 26.97 |
| Sorrento Therapeutics | 0.20 | 2.09M | NEW | 2.67 |
| Alimera Sciences (ALIM) | 0.19 | 6.05M | 0.89 | |
| Teligent Inc New bond | 0.18 | 9.57M | 0.53 | |
| Ideaya Biosciences Inc | 0.15 | 425000 | NEW | 9.96 |
| BioDelivery Sciences International (BDSI) | 0.14 | 816096 | NEW | 4.65 |
| Medicines Company (MDCO) | 0.13 | 100000 | NEW | 36.47 |
| Harpoon Therapeutics Inc | 0.13 | 285000 | 13.00 | |
| Aeglea Biotherapeutics | 0.12 | 500046 | 6.85 | |
| Itamar Med Ltd sponsored ads | 0.12 | 314136 | 11.00 | |
| Adaptive Biotechnologies Cor | 0.12 | 70000 | NEW | 48.30 |
| Pfenex | 0.10 | 394255 | -57% | 6.74 |
| Constellation Pharmceticls I | 0.08 | 183600 | -27% | 12.28 |
| Neuronetics Inc | 0.07 | 159000 | 12.51 | |
| Alpine Immune Sciences | 0.06 | 415908 | -12% | 4.21 |
| Eyenovia Inc equity | 0.05 | 300000 | 4.30 | |
| Orthopediatrics Corp. | 0.04 | 32000 | 39.00 | |
| Menlo Therapeutics Inc | 0.04 | 198451 | 5.99 | |
| Proteon Therapeutics | 0.02 | 1.22M | 0.42 | |
| Neos Therapeutics | 0.01 | 320993 | -82% | 1.29 |
Download CSV 
Past 13F-HR SEC Filings by Deerfield Management Company
- Deerfield Management Company 2019 Q1 filed May 15, 2019
- Deerfield Management Company 2018 Q4 filed Feb. 14, 2019
- Deerfield Management Company 2018 Q3 filed Nov. 14, 2018
- Deerfield Management Company 2018 Q2 filed Aug. 14, 2018
- Deerfield Management Company 2018 Q1 filed May 15, 2018
- Deerfield Management Company 2017 Q4 filed Feb. 14, 2018
- Deerfield Management 2017 Q3 filed Nov. 13, 2017
- Deerfield Management 2017 Q2 filed Aug. 14, 2017
- Deerfield Management 2017 Q1 filed May 15, 2017
- Deerfield Management 2016 Q4 filed Feb. 14, 2017
- Deerfield Management 2016 Q3 filed Nov. 14, 2016
- Deerfield Management 2016 Q2 filed Aug. 15, 2016
- Deerfield Management 2016 Q1 filed May 16, 2016
- Deerfield Management 2015 Q4 filed Feb. 16, 2016
- Deerfield Management 2015 Q3 filed Nov. 16, 2015
- Deerfield Management 2015 Q1 filed May 15, 2015
- Deerfield Management 2014 Q4 filed Feb. 17, 2015
- Deerfield Management 2014 Q3 filed Nov. 14, 2014
- Deerfield Management 2014 Q2 filed Aug. 14, 2014